INmune Bio (INMB) Insider Trading & Ownership → Your $200 account credit is about to expire (From MarketBeat) (Ad) Free INMB Stock Alerts $11.69 +0.06 (+0.52%) (As of 01:13 PM ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media INmune Bio (NASDAQ:INMB) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage36.10%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$48,650.00Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$110,100.00 Get INMB Insider Trade Alerts Want to know when executives and insiders are buying or selling INmune Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address INMB Insider Buying and Selling by Quarter Ad Crypto Swap ProfitsDid You Get Your Free Bitcoin Yet?And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here INmune Bio Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/10/2023Scott JudaDirectorBuy7,000$6.95$48,650.00 7/12/2023Timothy J SchroederDirectorSell10,000$11.01$110,100.00 (Data available from 1/1/2013 forward) INMB Insider Trading Activity - Frequently Asked Questions Who is on INmune Bio's Insider Roster? The list of insiders at INmune Bio includes David J Moss, Mark William Lowdell, Raymond Joseph Tesi, Scott Juda, and Timothy J Schroeder. Learn more on insiders at INMB. What percentage of INmune Bio stock is owned by insiders? 36.10% of INmune Bio stock is owned by insiders. Learn more on INMB's insider holdings. Which INmune Bio insiders have been buying company stock? The following insiders have purchased INMB shares in the last 24 months: David J Moss ($64,329.00), Raymond Joseph Tesi ($40,383.00), and Scott Juda ($48,650.00). How much insider buying is happening at INmune Bio? Insiders have purchased a total of 23,500 INMB shares in the last 24 months for a total of $153,362.00 bought. Which INmune Bio insiders have been selling company stock? The following insider sold INMB shares in the last 24 months: Timothy J Schroeder ($110,100.00). How much insider selling is happening at INmune Bio? Insiders have sold a total of 10,000 INmune Bio shares in the last 24 months for a total of $110,100.00 sold. More Insider Trading Tools from MarketBeat Related Companies: Vaxart Insider Buying Omega Therapeutics Insider Buying Elevation Oncology Insider Buying Graphite Bio Insider Buying Sutro Biopharma Insider Buying Cardiff Oncology Insider Buying Acumen Pharmaceuticals Insider Buying X4 Pharmaceuticals Insider Buying Agenus Insider Buying Black Diamond Therapeutics Insider Buying Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Stocks Insiders Are Buying That Analysts LoveInsider Selling of Amazon Spikes in Q1, but it's Not Time to Sell3 Small Dividend Paying Banks Insiders are Buying3 Stocks Insiders are Buying at New HighsInsider selling at JPM: A Closer Look Amidst Historic CEO Sale This page (NASDAQ:INMB) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersGrab Your Free Bitcoin Today!Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders Alliance“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThe 3rd Revolution in WarfareWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding INmune Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.